Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution
ConclusionsRP with neoadjuvant CHT using EMP for high-risk PCa patients provided excellent long-term OS.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Hormones | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Prostate Cancer | Study